Facts & Figures

Selected key financial figures

In EUR mio.	2024	2023	2022
Revenues	4,75	9,06	11,39
Operating result	-7,60	-5,00	-4,64
Loss for the year	-15,42	-6,37	-6,05
Cash and cash equivalents per 31.12.	1,71	2,56	8,15
Balance sheet total per 31.12.	8,18	12,36	19,88
Net cash flow	-0,9	-5,6	2,4

Tobias Meister

Investor Relations

ir@marinomed.com

Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com